Building Racial Equity into the Drug Development System

December 7, 2020

Kaiser Permanente’s Institute for Health Policy invites you to join a two-part virtual forum examining racial equity in the drug development system, from research all the way through to access. This first conversation on December 7 will specifically explore racial inequities in drug investment and research and identify new directions for the future.

This webinar was the first of a two-part virtual forum examining racial equity in the drug development system, from research all the way through to access.

The conversation specifically explored racial inequities in drug investment and research and identified new directions for the future.

Watch the video Speakers Agenda

Full event video

Our speakers

Priti Krishtel, JD

Co-Founder, Co-Executive Director, I-MAK

Rojelio Mejia, MD

Assistant professor of infectious diseases and pediatrics, National School of Tropical Medicine, Baylor College of Medicine

Uriridiakoghene “Ulili” Onovakpuri, MBA

Partner, Kapor Capital

Hannah Valantine, MD

Stanford Medicine, Professor of Medicine Former NIH Chief Scientific Officer for Scientific Workforce Diversity

Agenda

9:30 - 9:40 a.m.	Opening remarks
9:40 - 10:00 a.m.	Keynote: A framework for understanding structural racism in the medicines system
10- 10:55 a.m.	Panel: In whose interests? Building racial equity into pharmaceutical investment and funding
10:55 - 11:00 a.m.	Closing remarks

Health policy topics

Events

Publications

Building Racial Equity into the Drug Development System

This webinar was the first of a two-part virtual forum examining racial equity in the drug development system, from research all the way through to access.

Full event video

Agenda

Full event video

Keynote

Panel discussion